⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SynexCare and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SynexCare
↗Lomianki, Poland
SynexCare is a Polish medtech company founded in 2021 that develops advanced biosignal monitoring technologies. Their solutions integrate machine learning algorithms with classical signal analysis to support cardiology diagnostics, enabling large-scale screening and continuous monitoring of physiological parameters.
The company focuses on providing medical-grade diagnostic support, helping clinicians identify irregular heart rhythms and other cardiovascular abnormalities. Their platform is designed to meet regulatory requirements for modern healthcare, including EU Medical Device Regulation (MDR) standards.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Digital Health / Cardiology Diagnostics
SIZE & FINANCIALS
Employees:1-50
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Chicago Poland Ventures, Medi Ventures
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Digital Health, AI/Machine Learning
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Marcin Leszek Gruchała - Management Board Member
LINKS
Website:synexcare.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SynexCare. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.